Bill115th CongressFiled Dec 11, 2018Health
S. 3738
Hatch-Waxman Integrity Act of 2018
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Dec 11, 2018)
Hatch-Waxman Integrity Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent a generic drug or biosimilar manufacturer from using a specific review process for challenging pharmaceutical drug or biologic patents.
What just happenedDec 11, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Hatch, Orrin G. [R-UT](R-UT)Sponsor
1 cosponsor1 R
1cosponsors1committees2actions1related bills7subjects
- Introduced in SenateDec 11, 2018
- Dec 11, 2018IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Dec 11, 2018IntroReferral10000
Introduced in Senate